Newsroom

Industry News

21 Mar

George Bickerstaff Elected to Inovio’s Board of Directors

PLYMOUTH MEETING, Pa., March 21, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) announced today the election of George Bickerstaff to its Board of Directors. Mr. Bickerstaff is an internationally recognized expert in finance, healthcare and information technology.  He has served Novartis Pharma AG as its chief financial officer...

Read more

21 Mar

Youngevity International, Inc (YGYI) to Host Full Year 2016 Earnings Call

SAN DIEGO, CA–(Marketwired – Mar 21, 2017) – Youngevity International, Inc. ( OTCQX : YGYI ) (www.YGYI.com), a leading omni-direct lifestyle company, announced today that it will host a conference call on Thursday, March 30th at 4:15 PM Eastern Daylight Time (1:15 PM Pacific Daylight Time), to discuss the...

Read more

21 Mar

Onconova Therapeutics, Inc. to Present at Two Upcoming Healthcare Conferences

NEWTOWN, Pa., March 21, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that Company management will present an overview at the Sachs Fifth Annual Cancer Bio Partnering and Investment Forum,...

Read more

20 Mar

Nemus Bioscience Signs Development Agreement with Nanomerics to Advance Ocular Formulation of NB1111 for the Treatment of Glaucoma Using Proprietary Molecular Envelope Technology (MET)

COSTA MESA, CA–(Marketwired – Mar 20, 2017) – NEMUS Bioscience, Inc. ( OTCQB : NMUS ) announced that the company has signed a development agreement with Nanomerics Ltd. of the United Kingdom, to develop a topical ocular formulation of tetrahydrocannabinol-valine-hemisuccinate (THCVHS), the prodrug of THC, which is the active...

Read more

17 Mar

Actinium Pharmaceuticals to Sponsor 4th Annual Summit on Hematologic Malignancies

NEW YORK, March 16, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc.  (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that the Company is a sponsor of Oncology Meeting Innovations’ 4thAnnual Summit on Hematologic Malignancies, which is...

Read more

17 Mar

Cytori to Webcast Fourth Quarter Financial Results on March 23rd

SAN DIEGO, March 17, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX) will provide a live webcast of its fourth quarter financial results and business update on Thursday, March 23, 2017 at 5:30 PM Eastern Time. The dial-in information is as follows: Dial-In Number: +1.877.402.3914 Conference ID: 90778155 Prior...

Read more

17 Mar

Nephros Announces $1.2 Million Private Placement

RIVER EDGE, NJ–(Marketwired – Mar 17, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

Page 30 of 250« First...1020...2829303132...405060...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address